Hangzhou AGS MedTech Co., Ltd. (SHA:688581)
50.49
-0.14 (-0.28%)
At close: Nov 13, 2026
Hangzhou AGS MedTech Revenue
Hangzhou AGS MedTech had revenue of 111.65M CNY in the quarter ending September 30, 2026, a decrease of -28.84%. This brings the company's total for the last twelve months to 547.63M, down -18.10% year-over-year. In the year 2025, Hangzhou AGS MedTech had annual revenue of 593.74M, down -6.74%. That makes Hangzhou AGS MedTech the 24,211th largest company in the world by revenue and 4,352nd in China.
Revenue (ttm)
547.63M
Revenue Growth
-18.10%
P/S Ratio
7.44
Revenue / Employee
703.00K
Employees
779
Market Cap
4.08B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Hangzhou AGS MedTech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 593.74M | -42.89M | -6.74% |
| Dec 31, 2024 | 636.63M | 127.89M | 25.14% |
| Dec 31, 2023 | 508.75M | 137.64M | 37.09% |
| Dec 31, 2022 | 371.11M | 65.65M | 21.49% |
| Dec 31, 2021 | 305.47M | 133.51M | 77.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Huakang Century Clean Technology | 2.63B |
| Getein Biotech | 1.11B |
| Zhejiang Orient Gene Biotech | 993.10M |
| SWS Hemodialysis Care | 959.44M |
| Shanghai Aohua Photoelectricity Endoscope | 806.07M |
| Shanghai Kinetic Medical | 734.04M |
| Ningbo David Medical Device | 612.67M |
| Shanghai Sanyou Medical | 591.46M |